Can Zepbound costs really be a tax deduction? We checked
Quick answer
Tirzepatide (Zepbound) is a dual GLP-1/GIP receptor agonist FDA-approved for weight management. In the SURMOUNT-1 trial, 15mg tirzepatide led to 22.5% average weight loss over 72 weeks. Monthly costs range from $1,060 without insurance to $25-550 with manufacturer savings programs.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What does this video actually claim?
@madisonsecretlibrary's TikTok suggests that Zepbound costs can be claimed as tax deductions or somehow generate money during tax season. The video's caption combines #zepbound with #taxseason and #money, implying a financial benefit.
The creator doesn't spell out exactly how this works, but the implication is clear: you can get money back on your Zepbound expenses. This kind of content has exploded on TikTok as GLP-1 medications like tirzepatide (Zepbound) cost $1,000+ monthly without insurance.
The video has racked up 244,400 views, suggesting people are hungry for ways to offset these costs.
Can you actually deduct prescription drug costs?
Yes, but there's a massive catch that the video doesn't mention. Prescription medications only qualify as tax-deductible medical expenses if your total medical costs exceed 7.5% of your adjusted gross income (AGI).
For someone making $60,000 annually, medical expenses would need to top $4,500 before any deduction kicks in. Even with Zepbound's $12,000+ annual cost, you'd only deduct the amount above that threshold.
The creator makes this sound like automatic money back. It's not. Most people never hit the 7.5% AGI threshold, making this advice useless for the majority of viewers.
What about Health Savings Accounts?
HSAs offer a better path than standard deductions, but again, it's not as simple as the video suggests. You can use HSA funds for prescription medications like Zepbound without the 7.5% AGI limitation.
However, you need a qualifying high-deductible health plan to contribute to an HSA. The 2024 contribution limit is $4,300 for individuals, which covers less than half of Zepbound's annual cost.
FSAs work similarly but with even lower contribution limits ($3,200 for 2024) and use-it-or-lose-it rules. These accounts help, but they're not the financial windfall the video implies.
What's the real cost situation with Zepbound?
Zepbound (tirzepatide) costs roughly $1,060 monthly without insurance. That's $12,720 annually for a medication that showed 22.5% average weight loss in the SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022).
Eli Lilly offers a savings card that can reduce costs to $25-550 monthly for eligible patients, but this excludes government insurance plans. Most insurance plans don't cover Zepbound for weight loss, though some cover Mounjaro (same drug) for diabetes.
The financial reality is harsh: most people pay full price. Tax strategies help some people, but they're not the easy money-maker this video suggests.
What should you know about GLP-1 medication costs?
Don't count on tax deductions to make these medications affordable. The 7.5% AGI threshold eliminates most people from meaningful deductions, and the video oversells this strategy.
Better options include manufacturer savings programs, patient assistance programs, or shopping compounding pharmacies (though quality varies). Some telehealth platforms negotiate lower prices, though you'll still pay hundreds monthly.
If you're considering Zepbound, budget for $500-1,000 monthly out of pocket. The medication works (15mg tirzepatide produced 22.5% weight loss versus 2.4% for placebo in SURMOUNT-1), but the costs are real and ongoing.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Compounded Tirzepatide access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Can Zepbound costs really be a tax deduction? We checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Tirzepatide Once Weekly for the Treatment of Obesity
Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.
PubMed
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction
Used for continuation, stopping, and maintenance questions after initial weight loss.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Compounded Tirzepatide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this tirzepatide video claims cluster
Best for searchers deciding whether tirzepatide claims are stronger, safer, or more relevant than semaglutide claims.
Claim verdict
The useful answer behind this video
Claim being checked
Tirzepatide (Zepbound) is a dual GLP-1/GIP receptor agonist FDA-approved for weight management.
FormBlends verdict
Tirzepatide (Zepbound) is a dual GLP-1/GIP receptor agonist FDA-approved for weight management. In the SURMOUNT-1 trial, 15mg tirzepatide led to 22.5% average weight loss over 72 weeks. Monthly costs range from $1,060 without insurance to $25-550 with manufacturer savings programs.
Patient-safe next step
Compare the claim with the Compounded Tirzepatide guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Tirzepatide (Zepbound) is a dual GLP-1/GIP receptor agonist FDA-approved for weight management. In the SURMOUNT-1 trial, 15mg tirzepatide led to 22.5% average weight loss over 72 weeks. Monthly costs range from $1,060 without insurance to $25-550 with manufacturer savings programs.
- Prescription drug deductions only apply when total medical costs exceed 7.5% of your adjusted gross income
- Zepbound costs approximately $12,720 annually without insurance coverage
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compounded Tirzepatide decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the Compounded Tirzepatide guide, cost path, safety notes, and provider review before acting.
Review Compounded TirzepatideWhat You'll Learn
- Prescription drug deductions only apply when total medical costs exceed 7.5% of your adjusted gross income
- Zepbound costs approximately $12,720 annually without insurance coverage
- HSA contributions max at $4,300 annually for individuals in 2024, covering less than half of Zepbound's cost
- Tirzepatide 15mg produced 22.5% average weight loss in the 72-week SURMOUNT-1 trial
- Manufacturer savings cards can reduce costs to $25-550 monthly for eligible patients
- Tax deductions provide partial savings based on your tax bracket, not full refunds
- Most insurance plans don't cover GLP-1 medications prescribed specifically for weight loss
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
madisonsecretlibrary · TikTok creator
244.4K views on this video
Get that money!! #zepbound #taxseason #money
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by madisonsecretlibrary, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.